{"name": "Abbott Labs",
 "permalink": "abbott",
 "crunchbase_url": "http://www.crunchbase.com/company/abbott",
 "homepage_url": "http://www.abbott.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 133,
 "founded_year": 1991,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "224-361-7800",
 "description": "Genomic Disease Management",
 "created_at": "Wed Sep 03 21:51:05 UTC 2008",
 "updated_at": "Fri May 04 05:04:30 UTC 2012",
 "overview": "\u003Cp\u003EAbbott Molecular Inc., a genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases. It currently markets seven U.S. Food and Drug Administration or foreign cleared or approved clinical products in addition to distributing over 300 Analyte Specific Reagent and research products through its direct sales operations in the United States and Europe and a worldwide distribution network covering 59 countries. The company was founded in 1991 and is based in Des Plaines, Illinois. As on 12/05/2001, Abbott Molecular Inc. operates as a subsidiary of Abbott Laboratories Inc.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[149,
       69],
      "assets/images/resized/0002/9704/29704v2-max-150x150.png"],
     [[149,
       69],
      "assets/images/resized/0002/9704/29704v2-max-250x250.png"],
     [[149,
       69],
      "assets/images/resized/0002/9704/29704v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "John",
      "last_name": "L. Bishop",
      "permalink": "john-l-bishop",
      "image": null}},
   {"is_past": false,
    "title": "Division Director",
    "person":
     {"first_name": "Jeffrey",
      "last_name": "Boily",
      "permalink": "jeffrey-boily",
      "image": null}},
   {"is_past": true,
    "title": "various roles including Venture Head",
    "person":
     {"first_name": "Dr.",
      "last_name": "Bruce G. McCarthy",
      "permalink": "dr-bruce-g-mccarthy",
      "image": null}},
   {"is_past": true,
    "title": "Senior Sales Representative",
    "person":
     {"first_name": "Randy",
      "last_name": "Cheung",
      "permalink": "randy-cheung",
      "image":
       {"available_sizes":
         [[[120,
            150],
           "assets/images/resized/0025/8923/258923v1-max-150x150.jpg"],
          [[150,
            187],
           "assets/images/resized/0025/8923/258923v1-max-250x250.jpg"],
          [[150,
            187],
           "assets/images/resized/0025/8923/258923v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "marketing positions ",
    "person":
     {"first_name": "Dennis",
      "last_name": "H. Langer",
      "permalink": "dennis-h-langer",
      "image":
       {"available_sizes":
         [[[80,
            100],
           "assets/images/resized/0026/7891/267891v1-max-150x150.jpg"],
          [[80,
            100],
           "assets/images/resized/0026/7891/267891v1-max-250x250.jpg"],
          [[80,
            100],
           "assets/images/resized/0026/7891/267891v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Director of Product Development",
    "person":
     {"first_name": "Charles",
      "last_name": "Nelson",
      "permalink": "charles-nelson",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5900/255900v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5900/255900v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5900/255900v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Senior Marketing Positions",
    "person":
     {"first_name": "Patrick",
      "last_name": "Sullivan",
      "permalink": "patrick-sullivan-2",
      "image":
       {"available_sizes":
         [[[150,
            132],
           "assets/images/resized/0026/7609/267609v1-max-150x150.jpg"],
          [[179,
            158],
           "assets/images/resized/0026/7609/267609v1-max-250x250.jpg"],
          [[179,
            158],
           "assets/images/resized/0026/7609/267609v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Manager",
    "person":
     {"first_name": "Javier",
      "last_name": "Saade",
      "permalink": "javier-saade",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "d",
      "source_url": "http://venturebeat.com/2007/11/27/evalve-pulls-in-60m-heating-up-heart-valve-implant-race/",
      "source_description": "Evalve pulls in $60M, heating up heart-valve implant race",
      "raised_amount": 60000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2007,
      "funded_month": 11,
      "funded_day": 27,
      "company":
       {"name": "Evalve",
        "permalink": "evalve",
        "image":
         {"available_sizes":
           [[[150,
              45],
             "assets/images/resized/0006/0050/60050v1-max-150x150.jpg"],
            [[213,
              65],
             "assets/images/resized/0006/0050/60050v1-max-250x250.jpg"],
            [[213,
              65],
             "assets/images/resized/0006/0050/60050v1-max-450x450.jpg"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "b",
      "source_url": "http://onbiovc.com/ovalis-inc-series-b-66m/",
      "source_description": "Ovalis, Inc.: Series B $6.6M",
      "raised_amount": 6600000.0,
      "raised_currency_code": "USD",
      "funded_year": 2007,
      "funded_month": 1,
      "funded_day": 30,
      "company":
       {"name": "Ovalis",
        "permalink": "ovalis",
        "image": null}}}],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 215000000.0,
    "price_currency_code": "USD",
    "term_code": "stock",
    "source_url": "http://www.reuters.com/article/pressRelease/idUS143311+06-Jan-2009+PRN20090106",
    "source_description": "Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis",
    "acquired_year": 2008,
    "acquired_month": 12,
    "acquired_day": 17,
    "company":
     {"name": "Ibis Biosciences",
      "permalink": "ibis-biosciences",
      "image":
       {"available_sizes":
         [[[150,
            74],
           "assets/images/resized/0005/8754/58754v2-max-150x150.jpg"],
          [[250,
            124],
           "assets/images/resized/0005/8754/58754v2-max-250x250.jpg"],
          [[270,
            134],
           "assets/images/resized/0005/8754/58754v2-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": 410000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercepharma.com/story/studies-find-botox-cuts-migraine-days-abbott-buy-evalve-410m/2009-09-11#ixzz0SRZaqkm1",
    "source_description": "Studies find Botox cuts migraine days; Abbott to buy Evalve for up to $410M",
    "acquired_year": 2009,
    "acquired_month": 9,
    "acquired_day": 11,
    "company":
     {"name": "Evalve",
      "permalink": "evalve",
      "image":
       {"available_sizes":
         [[[150,
            45],
           "assets/images/resized/0006/0050/60050v1-max-150x150.jpg"],
          [[213,
            65],
           "assets/images/resized/0006/0050/60050v1-max-250x250.jpg"],
          [[213,
            65],
           "assets/images/resized/0006/0050/60050v1-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": 400000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.smartmoney.com/news/ON/?story=ON-20090902-000594-1636\u0026",
    "source_description": "Abbott To Pay $400 Million For Cataract-Treatment Firm Visiogen",
    "acquired_year": 2009,
    "acquired_month": 9,
    "acquired_day": 3,
    "company":
     {"name": "Visiogen",
      "permalink": "visiogen",
      "image":
       {"available_sizes":
         [[[89,
            72],
           "assets/images/resized/0005/0587/50587v1-max-150x150.jpg"],
          [[89,
            72],
           "assets/images/resized/0005/0587/50587v1-max-250x250.jpg"],
          [[89,
            72],
           "assets/images/resized/0005/0587/50587v1-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": 6600000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/abbott-buy-solvay-pharma-unit-6-6b-deal/2009-09-28?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0#ixzz0SRYxiv3p",
    "source_description": "Abbott to buy Solvay pharma unit in $6.6B deal  ",
    "acquired_year": 2009,
    "acquired_month": 9,
    "acquired_day": 28,
    "company":
     {"name": "Solvay Pharmaceuticals",
      "permalink": "solvay-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[90,
            90],
           "assets/images/resized/0006/0042/60042v1-max-150x150.png"],
          [[90,
            90],
           "assets/images/resized/0006/0042/60042v1-max-250x250.png"],
          [[90,
            90],
           "assets/images/resized/0006/0042/60042v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": 450000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/breaking-news-abbott-buys-facet-biotech-450m/2010-03-09?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Abbott buys Facet Biotech for $450M",
    "acquired_year": 2010,
    "acquired_month": 3,
    "acquired_day": 9,
    "company":
     {"name": "Facet Biotech",
      "permalink": "facet-biotech",
      "image":
       {"available_sizes":
         [[[115,
            90],
           "assets/images/resized/0007/9791/79791v1-max-150x150.jpg"],
          [[115,
            90],
           "assets/images/resized/0007/9791/79791v1-max-250x250.jpg"],
          [[115,
            90],
           "assets/images/resized/0007/9791/79791v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "1300 East Touhy",
    "address2": "",
    "zip_code": "60018-3315",
    "city": "Des Plaines",
    "state_code": "IL",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Abbott Buys Action Pharma Hormone For $110M ",
    "stoned_year": 2012,
    "stoned_month": 5,
    "stoned_day": 3,
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020120503e853v2ask\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120503e853v2ask%26from%3dalert%26pid%3d32",
    "source_text": "",
    "source_description": "Abbott Buys Action Pharma Hormone For $110M ",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Abbott Labs",
      "permalink": "abbott"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NYSE:ABT"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        86],
       "assets/images/resized/0007/9792/79792v1-max-150x150.jpg"],
      [[250,
        144],
       "assets/images/resized/0007/9792/79792v1-max-250x250.jpg"],
      [[450,
        260],
       "assets/images/resized/0007/9792/79792v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}